Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Tributyl O-acetylcitrate

EC / List no: 201-067-0 CAS no: 77-90-7
Concern
Endocrine disruption
Status
Concluded
Outcome
No need to initiate further regulatory risk management action at this time
Follow-up
None
Date of intention
12/11/2014
Date of RMOA conclusion
07/11/2016
RMOA conclusion document
Full RMOA document
Remarks
Reason for selecting the substance for hazard assessment development: substance known/suspected to be used as an alternative to a SVHC already on the Candidate List.
Authority
France
Submitter organisation
Ministry of Ecology, Sustainable Development and Energy
Submitter email
rmoa-fr@developpement-durable.gouv.fr
Submitter phone
Submitter address
Ministry of Ecology, Sustainable Development and Energy MEDDE - 92055 - La Defense cedex
Co-submitter(s)
Latest update
07/11/2016

Categories Display


Route: .live2